BioSig Announces 3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
| BSGM Stock | USD 1.34 0.04 3.08% |
About 55% of BioSig Technologies,'s investors are presently thinking to get in. The analysis of overall sentiment of trading BioSig Technologies, Common otc stock suggests that some investors are interested at this time. BioSig Technologies,'s investing sentiment overview a quick insight into current market opportunities from investing in BioSig Technologies, Common. Many technical investors use BioSig Technologies, stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
BioSig Technologies, otc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of BioSig daily returns and investor perception about the current price of BioSig Technologies, Common as well as its diversification or hedging effects on your existing portfolios.
BioSig |
Westport, CT, May 30, 2024 -- BioSig Technologies, Inc. a medical technology company committed to delivering unprecedented accuracy and precision to intracardiac signal visualization, today announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 1,570,683 shares of its common stock at a purchase price of 1.91 per share in a registered direct offering priced at-the-market under Nasdaq rules.
Read at finance.yahoo.com
 |
BioSig Technologies, Fundamental Analysis
We analyze BioSig Technologies,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioSig Technologies, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioSig Technologies, based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
BioSig Technologies, is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
BioSig Technologies, Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BioSig Technologies, otc stock to make a market-neutral strategy. Peer analysis of BioSig Technologies, could also be used in its relative valuation, which is a method of valuing BioSig Technologies, by comparing valuation metrics with similar companies.
Peers
BioSig Technologies, Related Equities
| HSCS | Heart Test | 11.99 | ||||
| VVOS | Vivos Therapeutics | 6.87 | ||||
| CLPT | Clearpoint Neuro | 6.07 | ||||
| TIVC | Tivic Health | 5.00 | ||||
| CTSO | Cytosorbents Crp | 4.55 | ||||
| LUNG | Pulmonx Corp | 3.71 | ||||
| BMRA | Biomerica | 3.70 | ||||
| NPCE | Neuropace | 3.50 | ||||
| NMTC | Neuroone Medical | 2.70 | ||||
| INGN | Inogen | 2.05 | ||||
| TELA | Tela Bio | 1.79 | ||||
| APYX | Apyx Medical | 0.64 | ||||
| SRDX | SurModics | 0.40 | ||||
| KIDS | Orthopediatrics Corp | 0.93 | ||||
| NUWE | Nuwellis | 0.99 | ||||
| BJDX | Bluejay Diagnostics | 1.54 | ||||
| BBLG | Bone Biologics | 3.81 | ||||
| XAIR | Beyond Air | 4.76 | ||||
| NAOV | NanoVibronix | 4.92 |
Other Information on Investing in BioSig OTC Stock
BioSig Technologies, financial ratios help investors to determine whether BioSig OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioSig with respect to the benefits of owning BioSig Technologies, security.